Synoligo Biotechnologies Launches Cutting-Edge E-commerce Platform for Oligonucleotide Synthesis, Empowering Researchers with Streamlined Access

MORRISVILLE, N.C., July 23, 2025 /PRNewswire/ — Synoligo Biotechnologies Inc., a leader in custom oligonucleotide synthesis, has announced the launch of its new e-commerce website, transforming the way researchers access high-quality oligonucleotides. The platform addresses critical needs in the scientific community by offering unmatched convenience, speed, and customization for oligonucleotide synthesis orders.

The global market for oligonucleotide synthesis continues to grow rapidly, driven by expanding applications in diagnostics, therapeutics, and basic research. With this new digital solution, Synoligo aims to simplify the ordering process and enhance the overall experience for scientists worldwide.

With the launch of our new e-commerce platform and the second expansion of our facility this month, Synoligo is well positioned to compete alongside major industry players. And we’re just getting started. We’ll continue expanding our SynOptuma™ product portfolio to deliver advanced solutions that accelerate scientific discovery,” said Dr. Xibo Li, PhD, CEO.

Key features of the new platform include:

  • Intuitive Interface: Seamless navigation and user-friendly ordering experience.
  • Advanced Customization: Flexible input for oligonucleotide sequences, modifications, and scale.
  • Secure Transactions: Robust data protection and secure payment processing.
  • Fast Turnaround: Streamlined production and delivery timelines to meet tight research deadlines.

This launch reinforces Synoligo’s mission to advance scientific research and drive innovation in the biopharma sector. The new e-commerce platform is now live and accessible at https://shop.synoligo.com/

About Synoligo Biotechnologies, Inc.

Headquartered in Morrisville, NC, USA, Synoligo Biotechnologies is a Contract Research and Development Organization (CRDO) specialized in manufacturing complex and highly modified oligonucleotide for academic, biotech start-up and large pharmaceutical communities. Synoligo is a leading oligonucleotide manufacturing company providing high quality, cost-effective custom oligonucleotides at varying scales for research, diagnostic, and therapeutic applications.

View original content to download multimedia:https://www.prnewswire.com/news-releases/synoligo-biotechnologies-launches-cutting-edge-e-commerce-platform-for-oligonucleotide-synthesis-empowering-researchers-with-streamlined-access-302511346.html

SOURCE Synoligo Biotechnologies Inc.

Staff

Recent Posts

CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition

Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH),…

2 hours ago

Planet Classroom Opens 2026 With Eight New Short Films Spotlighting Artistry, Resilience, and Human Possibility

January slate brings global stories of music, education, humanitarian response, and ethical technology into classrooms…

3 hours ago

Best Tummy Tuck in Las Vegas

The Best Tummy Tuck in Las Vegas Is by Dr. Ahmed. LAS VEGAS, NV /…

3 hours ago

Who Is the Best FTM Top Surgeon in the U.S.?

The Best FTM top surgeon in the U.S is Dr. Sajan. SEATTLE, WA / ACCESS…

3 hours ago

Brain Signal-Based Control Moves Beyond the Lab as INSIDE Institute Demonstrates Real-World Non-Invasive BCI Breakthroughs

SAN FRANCISCO, Jan. 4, 2026 /PRNewswire/ -- The INSIDE Institute for NeuroAI has demonstrated that non-invasive…

21 hours ago